Skip to content

Released Aug 14, 2023, before the open

10-Q filed Aug 14, 2023, 45 days after period end · 0001789769-23-000085

Q2 2023 · 10-Q
Revenue—
Net Income-$18.66MN/M vs Q2 2022N/M vs Q1 2023
EPS Diluted-$2.87N/M vs Q2 2022N/M vs Q1 2023
Operating Income-$20,987,000N/M
Operating Cash Flowderived-$19,560,000N/M
Free Cash Flowderived-$26,540,000N/M

What the release said

The release

Same quarter

MetricQ2 2023Q2 2022Q2 2021Q2 2020
Revenue——$0.00$42.00K
Net Income-$18.66M-$58.99M-$35.31M-$9.20M
EPS Diluted-$2.87-$0.46-$0.27-$0.55

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Instil Bio, Inc. · CIK 1789769 · Engraved from SEC EDGAR